| scholarly article | Q13442814 |
| P2093 | author name string | Lin Xie | |
| Guangji Wang | |||
| Chong Chen | |||
| Yan Liang | |||
| Huimin Chen | |||
| Huimin Guo | |||
| Xiao Zheng | |||
| Jiajia Shen | |||
| Dian Kang | |||
| Yangfan Xu | |||
| Haofeng Li | |||
| P2860 | cites work | Diversity of the human intestinal microbial flora | Q24544241 |
| Effect of probiotics on central nervous system functions in animals and humans - a systematic review | Q26740447 | ||
| Gut microbial communities modulating brain development and function | Q26827364 | ||
| Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish | Q27324499 | ||
| The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling | Q28067017 | ||
| Animals in a bacterial world, a new imperative for the life sciences | Q28705526 | ||
| Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve | Q29616854 | ||
| The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems | Q30415125 | ||
| Endophytic fungi harbored in Panax notoginseng: diversity and potential as biological control agents against host plant pathogens of root-rot disease | Q33850004 | ||
| Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling | Q34230078 | ||
| Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines | Q34317012 | ||
| γ-Aminobutyric acid production by culturable bacteria from the human intestine. | Q34638462 | ||
| Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents | Q34760168 | ||
| Principles and clinical implications of the brain-gut-enteric microbiota axis | Q34978494 | ||
| Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells | Q35020335 | ||
| Protective effect of ginsenoside Rb1 against intestinal ischemia-reperfusion induced acute renal injury in mice | Q35063814 | ||
| Microbiota and the gut-brain axis | Q35691567 | ||
| Qualitatively and quantitatively investigating the regulation of intestinal microbiota on the metabolism of panax notoginseng saponins | Q36135954 | ||
| Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. | Q36245800 | ||
| Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats | Q36754833 | ||
| Comparative Study of White and Steamed Black Panax ginseng, P. quinquefolium, and P. notoginseng on Cholinesterase Inhibitory and Antioxidative Activity | Q36861025 | ||
| Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior | Q38163530 | ||
| GABA receptors in brain development, function, and injury | Q38211328 | ||
| GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation | Q38294950 | ||
| Bioconversion Using Lactic Acid Bacteria: Ginsenosides, GABA, and Phenolic Compounds | Q38744623 | ||
| Ginsenoside Rb1 as a neuroprotective agent: A review | Q38802758 | ||
| The Gut-Brain Axis, BDNF, NMDA and CNS Disorders. | Q38935172 | ||
| GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. | Q39235778 | ||
| Protective Effect of Ginsenoside Rb1 Against Lung Injury Induced by Intestinal Ischemia-Reperfusion in Rats | Q45790334 | ||
| Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. | Q45792647 | ||
| A semiautomated method for measuring brain infarct volume. | Q45954002 | ||
| Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders. | Q46346120 | ||
| Development of a systematic approach to rapid classification and identification of notoginsenosides and metabolites in rat feces based on liquid chromatography coupled triple time-of-flight mass spectrometry | Q47426415 | ||
| Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress | Q47640528 | ||
| Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides | Q48004594 | ||
| Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model | Q51853484 | ||
| Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion | Q52147819 | ||
| Development and validation of an UFLC-MS/MS assay for the absolute quantitation of nine notoginsenosides in rat plasma: Application to the pharmacokinetic study of Panax Notoginseng Extract | Q53673903 | ||
| The microbiome-gut-brain axis: from bowel to behavior | Q57513693 | ||
| Diagnostic ion filtering to characterize ginseng saponins by rapid liquid chromatography with time-of-flight mass spectrometry | Q83473702 | ||
| Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration | Q85892582 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | Lactobacillus helveticus | Q142378 |
| P304 | page(s) | 86-95 | |
| P577 | publication date | 2018-09-19 | |
| P1433 | published in | Journal of Ginseng Research | Q26841821 |
| P1476 | title | Ginsenoside Rb1 exerts neuroprotective effects through regulation of Lactobacillus helveticus abundance and GABAA receptor expression | |
| P478 | volume | 44 |
Search more.